This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klepser, M. E.
Right arrow Articles by Pfaller, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klepser, M. E.
Right arrow Articles by Pfaller, M. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 1998, p. 3653-3656, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Variation in Electrophoretic Karyotype and Antifungal Susceptibility of Clinical Isolates of Cryptococcus neoformans at a University-Affiliated Teaching Hospital from 1987 to 1994

Michael E. Klepser1,* and Michael A. Pfaller2

College of Pharmacy, The University of Iowa,1 and Department of Pathology, The University of Iowa Hospitals and Clinics,2 Iowa City, Iowa 52242

Received 2 February 1998/Returned for modification 2 March 1998/Accepted 24 September 1998

Ninety-eight isolates of Cryptococcus neoformans were collected from 30 patients at the University of Iowa Hospitals and Clinics from December 1987 through December 1994. The susceptibility of each isolate was determined against fluconazole, itraconazole, amphotericin B, and flucytosine. Of the 98 isolates, 53 were recovered from blood, 19 were recovered from cerebrospinal fluid (CSF), and 26 were recovered from other sources. Although the strains were isolated from the same institution, DNA typing by electrophoretic karyotype (EK) revealed wide genetic variation. Overall, 23 different EK profiles were identified by computer-aided analysis. An isolate exhibiting a single EK was isolated from 24 of 30 patients (80%), whereas multiple strains with unique EKs were isolated from 6 of 30 (20%) patients. Of the six patients who had multiple strains recovered, only one individual had two strains isolated from unique body sites, one strain from the blood and the other from the CSF. Six strains were isolated from multiple patients. Nine patients had multiple sequential isolates recovered over periods of time ranging from 3 days to 4 months. EK analysis revealed persistence of the same genotype in six of the cases. Three patients, however, appeared to have an isolate with a second distinct EK emerge during therapy. Of the patients with sequential positive cultures, an increase in the MICs for test agents was observed in only one case. C. neoformans isolates were collected over a period of 7 years, during which time MICs at our institution remained stable.


* Corresponding author. Mailing address: S412 Pharmacy Building, The University of Iowa College of Pharmacy, Iowa City, Iowa 52242-1112. Phone: (319) 335-8861. Fax: (319) 353-5646. E-mail: michael-klepser{at}uiowa.edu.


Journal of Clinical Microbiology, December 1998, p. 3653-3656, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Jain, N., Wickes, B. L., Keller, S. M., Fu, J., Casadevall, A., Jain, P., Ragan, M. A., Banerjee, U., Fries, B. C. (2005). Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from India. J. Clin. Microbiol. 43: 5733-5742 [Abstract] [Full Text]  
  • Mandal, P., Banerjee, U., Casadevall, A., Nosanchuk, J. D. (2005). Dual Infections with Pigmented and Albino Strains of Cryptococcus neoformans in Patients with or without Human Immunodeficiency Virus Infection in India. J. Clin. Microbiol. 43: 4766-4772 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Doern, G. V., Diekema, D. J. (2005). Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004). J. Clin. Microbiol. 43: 2163-2167 [Abstract] [Full Text]  
  • Garcia-Hermoso, D., Dromer, F., Janbon, G. (2004). Cryptococcus neoformans Capsule Structure Evolution In Vitro and during Murine Infection. Infect. Immun. 72: 3359-3365 [Abstract] [Full Text]  
  • Sukroongreung, S., Lim, S., Tantimavanich, S., Eampokalap, B., Carter, D., Nilakul, C., Kulkeratiyut, S., Tansuphaswadikul, S. (2001). Phenotypic Switching and Genetic Diversity of Cryptococcus neoformans. J. Clin. Microbiol. 39: 2060-2064 [Abstract] [Full Text]  
  • Xu, J., Onyewu, C., Yoell, H. J., Ali, R. Y., Vilgalys, R. J., Mitchell, T. G. (2001). Dynamic and Heterogeneous Mutations to Fluconazole Resistance in Cryptococcus neoformans. Antimicrob. Agents Chemother. 45: 420-427 [Abstract] [Full Text]